Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InMed Pharmaceuticals (INM) Other Non Operating Income (2021 - 2025)

Historic Other Non Operating Income for InMed Pharmaceuticals (INM) over the last 5 years, with Q4 2025 value amounting to $18136.0.

  • InMed Pharmaceuticals' Other Non Operating Income rose 13797.88% to $18136.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$38886.0, marking a year-over-year increase of 6180.27%. This contributed to the annual value of -$28471.0 for FY2025, which is 5402.04% up from last year.
  • Per InMed Pharmaceuticals' latest filing, its Other Non Operating Income stood at $18136.0 for Q4 2025, which was up 13797.88% from -$56994.0 recorded in Q3 2025.
  • Over the past 5 years, InMed Pharmaceuticals' Other Non Operating Income peaked at $59896.0 during Q4 2023, and registered a low of -$96791.0 during Q3 2022.
  • In the last 5 years, InMed Pharmaceuticals' Other Non Operating Income had a median value of -$12449.0 in 2023 and averaged -$16387.6.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first soared by 57299.63% in 2022, then crashed by 166201.98% in 2024.
  • Quarter analysis of 5 years shows InMed Pharmaceuticals' Other Non Operating Income stood at $3007.0 in 2021, then skyrocketed by 573.0% to $20237.0 in 2022, then surged by 195.97% to $59896.0 in 2023, then tumbled by 179.73% to -$47753.0 in 2024, then surged by 137.98% to $18136.0 in 2025.
  • Its Other Non Operating Income stands at $18136.0 for Q4 2025, versus -$56994.0 for Q3 2025 and $22137.0 for Q2 2025.